Research
Education
Solutions
Sign In
EN
EN - English
CN - 中文
DE - Deutsch
ES - Español
KR - 한국어
IT - Italiano
FR - Français
PT - Português
TR - Turkish
JA - Japanese
Division of Cancer & Stem Cells,
School of Medicine,
Nottingham Biodiscovery Institute,
Division of Cancer & Stem Cells, School of Medicine, Nottingham Biodiscovery Institute
Kataryna Lis-Slimak has not added Biography.
If you are Kataryna Lis-Slimak and would like to personalize this page please email our Author Liaison for assistance.
CRISPR/Cas9 editing in human pluripotent stem cell-cardiomyocytes highlights arrhythmias, hypocontractility, and energy depletion as potential therapeutic targets for hypertrophic cardiomyopathy.
European heart journal 11, 2018 | Pubmed ID: 29741611
Peptide gels of fully-defined composition and mechanics for probing cell-cell and cell-matrix interactions in vitro.
Matrix biology : journal of the International Society for Matrix Biology 01, 2020 | Pubmed ID: 31295578
High-Throughput Phenotyping Toolkit for Characterizing Cellular Models of Hypertrophic Cardiomyopathy In Vitro.
Methods and protocols Oct, 2019 | Pubmed ID: 31717790
University of Nottingham
Jennifer C. Ashworth1,
Rebecca L. Morgan1,
Kataryna Lis-Slimak1,
Kate A. Meade1,
Sal Jones1,
Katherine Spence2,
Charlotte E. Slater1,
Jamie L. Thompson1,
Anna M. Grabowska1,
Robert B. Clarke2,
Gilian Farnie3,
Cathy L. R. Merry1
1Division of Cancer & Stem Cells, School of Medicine, Nottingham Biodiscovery Institute, University of Nottingham,
2Breast Biology Group, Manchester Breast Centre, Division of Cancer Sciences, Faculty of Biology, Medicine and Health, University of Manchester,
3SGC, Botnar Research Centre, NDORMS, University of Oxford
Privacy
Terms of Use
Policies
Contact Us
Recommend to library
JoVE NEWSLETTERS
JoVE Journal
Methods Collections
JoVE Encyclopedia of Experiments
Archive
JoVE Core
JoVE Business
JoVE Science Education
JoVE Lab Manual
Faculty Resource Center
Authors
Librarians
Access
ABOUT JoVE
Copyright © 2024 MyJoVE Corporation. All rights reserved